#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Diy_coref|
#T_RL=webanno.custom.Diy_coref_re|BT_webanno.custom.Diy_coref


#Text=[0011] Accordingly, research has also been directed toward automatic responsive epilepsy treatment based on a detection of imminent seizure.
1-1	0-1	[	_	_	
1-2	1-5	0011	_	_	
1-3	5-6	]	_	_	
1-4	7-18	Accordingly	_	_	
1-5	18-19	,	_	_	
1-6	20-28	research	_	_	
1-7	29-32	has	_	_	
1-8	33-37	also	_	_	
1-9	38-42	been	_	_	
1-10	43-51	directed	_	_	
1-11	52-58	toward	_	_	
1-12	59-68	automatic	_	_	
1-13	69-79	responsive	_	_	
1-14	80-88	epilepsy	_	_	
1-15	89-98	treatment	_	_	
1-16	99-104	based	_	_	
1-17	105-107	on	_	_	
1-18	108-109	a	_	_	
1-19	110-119	detection	_	_	
1-20	120-122	of	_	_	
1-21	123-131	imminent	_	_	
1-22	132-139	seizure	_	_	
1-23	139-140	.	_	_	

#Text=Neuropace, Inc. is presently developing and conducting clinical trials on an implantable responsive neurostimulator for epilepsy.
2-1	141-150	Neuropace	_	_	
2-2	150-151	,	_	_	
2-3	152-155	Inc	_	_	
2-4	155-156	.	_	_	
2-5	157-159	is	_	_	
2-6	160-169	presently	_	_	
2-7	170-180	developing	_	_	
2-8	181-184	and	_	_	
2-9	185-195	conducting	_	_	
2-10	196-204	clinical	_	_	
2-11	205-211	trials	_	_	
2-12	212-214	on	_	_	
2-13	215-217	an	_	_	
2-14	218-229	implantable	_	_	
2-15	230-240	responsive	_	_	
2-16	241-256	neurostimulator	_	_	
2-17	257-260	for	_	_	
2-18	261-269	epilepsy	_	_	
2-19	269-270	.	_	_	

#Text=Once again, there are the risks involved with an implantable system.
3-1	271-275	Once	_	_	
3-2	276-281	again	_	_	
3-3	281-282	,	_	_	
3-4	283-288	there	_	_	
3-5	289-292	are	_	_	
3-6	293-296	the	_	_	
3-7	297-302	risks	_	_	
3-8	303-311	involved	_	_	
3-9	312-316	with	_	_	
3-10	317-319	an	_	_	
3-11	320-331	implantable	_	_	
3-12	332-338	system	_	_	
3-13	338-339	.	_	_	

#Text=For episodes where the focus of the seizure moves, or where there is no clear focus, it would be nearly impossible to place electrodes in every location where a seizure focus may be.
4-1	340-343	For	_	_	
4-2	344-352	episodes	_	_	
4-3	353-358	where	_	_	
4-4	359-362	the	_	_	
4-5	363-368	focus	_	_	
4-6	369-371	of	_	_	
4-7	372-375	the	_	_	
4-8	376-383	seizure	_	_	
4-9	384-389	moves	_	_	
4-10	389-390	,	_	_	
4-11	391-393	or	_	_	
4-12	394-399	where	_	_	
4-13	400-405	there	_	_	
4-14	406-408	is	_	_	
4-15	409-411	no	_	_	
4-16	412-417	clear	_	_	
4-17	418-423	focus	_	_	
4-18	423-424	,	_	_	
4-19	425-427	it	_	_	
4-20	428-433	would	_	_	
4-21	434-436	be	_	_	
4-22	437-443	nearly	_	_	
4-23	444-454	impossible	_	_	
4-24	455-457	to	_	_	
4-25	458-463	place	_	_	
4-26	464-474	electrodes	_	_	
4-27	475-477	in	_	_	
4-28	478-483	every	_	_	
4-29	484-492	location	_	_	
4-30	493-498	where	_	_	
4-31	499-500	a	_	_	
4-32	501-508	seizure	_	_	
4-33	509-514	focus	_	_	
4-34	515-518	may	_	_	
4-35	519-521	be	_	_	
4-36	521-522	.	_	_	

#Text=Compromises must be made to minimize the number of implanted electrodes and maximize the efficacy.
5-1	523-534	Compromises	_	_	
5-2	535-539	must	_	_	
5-3	540-542	be	_	_	
5-4	543-547	made	_	_	
5-5	548-550	to	_	_	
5-6	551-559	minimize	_	_	
5-7	560-563	the	_	_	
5-8	564-570	number	_	_	
5-9	571-573	of	_	_	
5-10	574-583	implanted	_	_	
5-11	584-594	electrodes	_	_	
5-12	595-598	and	_	_	
5-13	599-607	maximize	_	_	
5-14	608-611	the	_	_	
5-15	612-620	efficacy	_	_	
5-16	620-621	.	_	_	

#Text=Another major concern is that such a device cannot be implanted quick enough during an emergency seizure that is pharmaco-resistant.
#Text=[0012] Trigeminal nerve stimulation is also a possible method for desynchronizing seizure activity.
6-1	622-629	Another	_	_	
6-2	630-635	major	_	_	
6-3	636-643	concern	_	_	
6-4	644-646	is	_	_	
6-5	647-651	that	_	_	
6-6	652-656	such	_	_	
6-7	657-658	a	_	_	
6-8	659-665	device	_	_	
6-9	666-672	cannot	_	_	
6-10	673-675	be	_	_	
6-11	676-685	implanted	_	_	
6-12	686-691	quick	_	_	
6-13	692-698	enough	_	_	
6-14	699-705	during	_	_	
6-15	706-708	an	_	_	
6-16	709-718	emergency	_	_	
6-17	719-726	seizure	_	_	
6-18	727-731	that	_	_	
6-19	732-734	is	_	_	
6-20	735-753	pharmaco-resistant	_	_	
6-21	753-754	.	_	_	
6-22	755-756	[	_	_	
6-23	756-760	0012	_	_	
6-24	760-761	]	_	_	
6-25	762-772	Trigeminal	*[1]	9-4[2_1]	
6-26	773-778	nerve	*[1]	_	
6-27	779-790	stimulation	*[1]	_	
6-28	791-793	is	_	_	
6-29	794-798	also	_	_	
6-30	799-800	a	_	_	
6-31	801-809	possible	_	_	
6-32	810-816	method	_	_	
6-33	817-820	for	_	_	
6-34	821-836	desynchronizing	_	_	
6-35	837-844	seizure	_	_	
6-36	845-853	activity	_	_	
6-37	853-854	.	_	_	

#Text=Advanced Bionics, Inc. is currently developing an implantable device for the treatment of epilepsy that involves the application of electrical stimulation to the trigemnial nerve.
7-1	855-863	Advanced	_	_	
7-2	864-871	Bionics	_	_	
7-3	871-872	,	_	_	
7-4	873-876	Inc	_	_	
7-5	876-877	.	_	_	
7-6	878-880	is	_	_	
7-7	881-890	currently	_	_	
7-8	891-901	developing	_	_	
7-9	902-904	an	_	_	
7-10	905-916	implantable	_	_	
7-11	917-923	device	_	_	
7-12	924-927	for	_	_	
7-13	928-931	the	_	_	
7-14	932-941	treatment	_	_	
7-15	942-944	of	_	_	
7-16	945-953	epilepsy	_	_	
7-17	954-958	that	_	_	
7-18	959-967	involves	_	_	
7-19	968-971	the	_	_	
7-20	972-983	application	_	_	
7-21	984-986	of	_	_	
7-22	987-997	electrical	_	_	
7-23	998-1009	stimulation	_	_	
7-24	1010-1012	to	_	_	
7-25	1013-1016	the	_	_	
7-26	1017-1027	trigemnial	_	_	
7-27	1028-1033	nerve	_	_	
7-28	1033-1034	.	_	_	

#Text=As with the vagus nerve, the trigeminal nerve does not project to all areas of the brain and cannot stop all seizures.
8-1	1035-1037	As	_	_	
8-2	1038-1042	with	_	_	
8-3	1043-1046	the	_	_	
8-4	1047-1052	vagus	_	_	
8-5	1053-1058	nerve	_	_	
8-6	1058-1059	,	_	_	
8-7	1060-1063	the	_	_	
8-8	1064-1074	trigeminal	_	_	
8-9	1075-1080	nerve	_	_	
8-10	1081-1085	does	_	_	
8-11	1086-1089	not	_	_	
8-12	1090-1097	project	_	_	
8-13	1098-1100	to	_	_	
8-14	1101-1104	all	_	_	
8-15	1105-1110	areas	_	_	
8-16	1111-1113	of	_	_	
8-17	1114-1117	the	_	_	
8-18	1118-1123	brain	_	_	
8-19	1124-1127	and	_	_	
8-20	1128-1134	cannot	_	_	
8-21	1135-1139	stop	_	_	
8-22	1140-1143	all	_	_	
8-23	1144-1152	seizures	_	_	
8-24	1152-1153	.	_	_	

#Text=Once again, this method will have the same concerns for implantable devices as with the above-mentioned devices.
#Text=[0013] There has been only one anecdotal report in the literature about electroconvulsive therapy (ECT) use in medically intractable seizures in human patients (Griesemer et al., Neurology; 1997 49(5):1389-92): one patient experienced "change in a seizure pattern with cessation at higher intensity," while the other experienced "decrease in spontaneous seizure frequency".
9-1	1154-1158	Once	_	_	
9-2	1159-1164	again	_	_	
9-3	1164-1165	,	_	_	
9-4	1166-1170	this	*[2]	_	
9-5	1171-1177	method	*[2]	_	
9-6	1178-1182	will	_	_	
9-7	1183-1187	have	_	_	
9-8	1188-1191	the	_	_	
9-9	1192-1196	same	_	_	
9-10	1197-1205	concerns	_	_	
9-11	1206-1209	for	_	_	
9-12	1210-1221	implantable	_	_	
9-13	1222-1229	devices	_	_	
9-14	1230-1232	as	_	_	
9-15	1233-1237	with	_	_	
9-16	1238-1241	the	_	_	
9-17	1242-1257	above-mentioned	_	_	
9-18	1258-1265	devices	_	_	
9-19	1265-1266	.	_	_	
9-20	1267-1268	[	_	_	
9-21	1268-1272	0013	_	_	
9-22	1272-1273	]	_	_	
9-23	1274-1279	There	_	_	
9-24	1280-1283	has	_	_	
9-25	1284-1288	been	_	_	
9-26	1289-1293	only	_	_	
9-27	1294-1297	one	_	_	
9-28	1298-1307	anecdotal	_	_	
9-29	1308-1314	report	_	_	
9-30	1315-1317	in	_	_	
9-31	1318-1321	the	_	_	
9-32	1322-1332	literature	_	_	
9-33	1333-1338	about	_	_	
9-34	1339-1356	electroconvulsive	_	_	
9-35	1357-1364	therapy	_	_	
9-36	1365-1366	(	_	_	
9-37	1366-1369	ECT	_	_	
9-38	1369-1370	)	_	_	
9-39	1371-1374	use	_	_	
9-40	1375-1377	in	_	_	
9-41	1378-1387	medically	_	_	
9-42	1388-1399	intractable	_	_	
9-43	1400-1408	seizures	_	_	
9-44	1409-1411	in	_	_	
9-45	1412-1417	human	_	_	
9-46	1418-1426	patients	_	_	
9-47	1427-1428	(	_	_	
9-48	1428-1437	Griesemer	_	_	
9-49	1438-1440	et	_	_	
9-50	1441-1443	al	_	_	
9-51	1443-1444	.	_	_	
9-52	1444-1445	,	_	_	
9-53	1446-1455	Neurology	_	_	
9-54	1455-1456	;	_	_	
9-55	1457-1461	1997	_	_	
9-56	1462-1464	49	_	_	
9-57	1464-1465	(	_	_	
9-58	1465-1466	5	_	_	
9-59	1466-1467	)	_	_	
9-60	1467-1468	:	_	_	
9-61	1468-1472	1389	_	_	
9-62	1472-1473	-	_	_	
9-63	1473-1475	92	_	_	
9-64	1475-1476	)	_	_	
9-65	1476-1477	:	_	_	
9-66	1478-1481	one	_	_	
9-67	1482-1489	patient	_	_	
9-68	1490-1501	experienced	_	_	
9-69	1502-1503	"	_	_	
9-70	1503-1509	change	_	_	
9-71	1510-1512	in	_	_	
9-72	1513-1514	a	_	_	
9-73	1515-1522	seizure	_	_	
9-74	1523-1530	pattern	_	_	
9-75	1531-1535	with	_	_	
9-76	1536-1545	cessation	_	_	
9-77	1546-1548	at	_	_	
9-78	1549-1555	higher	_	_	
9-79	1556-1565	intensity	_	_	
9-80	1565-1566	,	_	_	
9-81	1566-1567	"	_	_	
9-82	1568-1573	while	_	_	
9-83	1574-1577	the	_	_	
9-84	1578-1583	other	_	_	
9-85	1584-1595	experienced	_	_	
9-86	1596-1597	"	_	_	
9-87	1597-1605	decrease	_	_	
9-88	1606-1608	in	_	_	
9-89	1609-1620	spontaneous	_	_	
9-90	1621-1628	seizure	_	_	
9-91	1629-1638	frequency	_	_	
9-92	1638-1639	"	_	_	
9-93	1639-1640	.	_	_	

#Text=Surprisingly, no further studies to investigate this methodology in an animal model or in a human clinical series are found.
10-1	1641-1653	Surprisingly	_	_	
10-2	1653-1654	,	_	_	
10-3	1655-1657	no	_	_	
10-4	1658-1665	further	_	_	
10-5	1666-1673	studies	_	_	
10-6	1674-1676	to	_	_	
10-7	1677-1688	investigate	_	_	
10-8	1689-1693	this	_	_	
10-9	1694-1705	methodology	_	_	
10-10	1706-1708	in	_	_	
10-11	1709-1711	an	_	_	
10-12	1712-1718	animal	_	_	
10-13	1719-1724	model	_	_	
10-14	1725-1727	or	_	_	
10-15	1728-1730	in	_	_	
10-16	1731-1732	a	_	_	
10-17	1733-1738	human	_	_	
10-18	1739-1747	clinical	_	_	
10-19	1748-1754	series	_	_	
10-20	1755-1758	are	_	_	
10-21	1759-1764	found	_	_	
10-22	1764-1765	.	_	_	

#Text=Electroconvulsive therapy (ECT) is performed using conventional EEG electrodes that are not capable of focusing stimulation to a specific volume of biological tissue.
11-1	1766-1783	Electroconvulsive	_	_	
11-2	1784-1791	therapy	_	_	
11-3	1792-1793	(	_	_	
11-4	1793-1796	ECT	_	_	
11-5	1796-1797	)	_	_	
11-6	1798-1800	is	_	_	
11-7	1801-1810	performed	_	_	
11-8	1811-1816	using	_	_	
11-9	1817-1829	conventional	_	_	
11-10	1830-1833	EEG	_	_	
11-11	1834-1844	electrodes	_	_	
11-12	1845-1849	that	_	_	
11-13	1850-1853	are	_	_	
11-14	1854-1857	not	_	_	
11-15	1858-1865	capable	_	_	
11-16	1866-1868	of	_	_	
11-17	1869-1877	focusing	_	_	
11-18	1878-1889	stimulation	_	_	
11-19	1890-1892	to	_	_	
11-20	1893-1894	a	_	_	
11-21	1895-1903	specific	_	_	
11-22	1904-1910	volume	_	_	
11-23	1911-1913	of	_	_	
11-24	1914-1924	biological	_	_	
11-25	1925-1931	tissue	_	_	
11-26	1931-1932	.	_	_	

#Text=To perform ECT, strong muscle relaxants, as well as sedation, are often used.
12-1	1933-1935	To	_	_	
12-2	1936-1943	perform	_	_	
12-3	1944-1947	ECT	_	_	
12-4	1947-1948	,	_	_	
12-5	1949-1955	strong	_	_	
12-6	1956-1962	muscle	_	_	
12-7	1963-1972	relaxants	_	_	
12-8	1972-1973	,	_	_	
12-9	1974-1976	as	_	_	
12-10	1977-1981	well	_	_	
12-11	1982-1984	as	_	_	
12-12	1985-1993	sedation	_	_	
12-13	1993-1994	,	_	_	
12-14	1995-1998	are	_	_	
12-15	1999-2004	often	_	_	
12-16	2005-2009	used	_	_	
12-17	2009-2010	.	_	_	

#Text=Thus, the patient must be monitored closely.
#Text=[0014] It has been proposed that if one can apply electrical stimulation at or near the foci, the origin of epileptiform activity, the efficacy of seizure control will be increased.
13-1	2011-2015	Thus	_	_	
13-2	2015-2016	,	_	_	
13-3	2017-2020	the	_	_	
13-4	2021-2028	patient	_	_	
13-5	2029-2033	must	_	_	
13-6	2034-2036	be	_	_	
13-7	2037-2046	monitored	_	_	
13-8	2047-2054	closely	_	_	
13-9	2054-2055	.	_	_	
13-10	2056-2057	[	_	_	
13-11	2057-2061	0014	_	_	
13-12	2061-2062	]	_	_	
13-13	2063-2065	It	_	_	
13-14	2066-2069	has	_	_	
13-15	2070-2074	been	_	_	
13-16	2075-2083	proposed	_	_	
13-17	2084-2088	that	_	_	
13-18	2089-2091	if	_	_	
13-19	2092-2095	one	_	_	
13-20	2096-2099	can	_	_	
13-21	2100-2105	apply	_	_	
13-22	2106-2116	electrical	_	_	
13-23	2117-2128	stimulation	_	_	
13-24	2129-2131	at	_	_	
13-25	2132-2134	or	_	_	
13-26	2135-2139	near	_	_	
13-27	2140-2143	the	_	_	
13-28	2144-2148	foci	_	_	
13-29	2148-2149	,	_	_	
13-30	2150-2153	the	_	_	
13-31	2154-2160	origin	_	_	
13-32	2161-2163	of	_	_	
13-33	2164-2176	epileptiform	_	_	
13-34	2177-2185	activity	_	_	
13-35	2185-2186	,	_	_	
13-36	2187-2190	the	_	_	
13-37	2191-2199	efficacy	_	_	
13-38	2200-2202	of	_	_	
13-39	2203-2210	seizure	_	_	
13-40	2211-2218	control	_	_	
13-41	2219-2223	will	_	_	
13-42	2224-2226	be	_	_	
13-43	2227-2236	increased	_	_	
13-44	2236-2237	.	_	_	

#Text=Finding the seizure foci usually involves very expensive and immobile imaging equipment, such as a functional magnetic resonance (fMRI) system.
14-1	2238-2245	Finding	_	_	
14-2	2246-2249	the	_	_	
14-3	2250-2257	seizure	_	_	
14-4	2258-2262	foci	_	_	
14-5	2263-2270	usually	_	_	
14-6	2271-2279	involves	_	_	
14-7	2280-2284	very	_	_	
14-8	2285-2294	expensive	_	_	
14-9	2295-2298	and	_	_	
14-10	2299-2307	immobile	_	_	
14-11	2308-2315	imaging	_	_	
14-12	2316-2325	equipment	_	_	
14-13	2325-2326	,	_	_	
14-14	2327-2331	such	_	_	
14-15	2332-2334	as	_	_	
14-16	2335-2336	a	_	_	
14-17	2337-2347	functional	_	_	
14-18	2348-2356	magnetic	_	_	
14-19	2357-2366	resonance	_	_	
14-20	2367-2368	(	_	_	
14-21	2368-2372	fMRI	_	_	
14-22	2372-2373	)	_	_	
14-23	2374-2380	system	_	_	
14-24	2380-2381	.	_	_	

#Text=Even with such an elaborate system, real-time analysis of the seizure activity still cannot be achieved.
15-1	2382-2386	Even	_	_	
15-2	2387-2391	with	_	_	
15-3	2392-2396	such	_	_	
15-4	2397-2399	an	_	_	
15-5	2400-2409	elaborate	_	_	
15-6	2410-2416	system	_	_	
15-7	2416-2417	,	_	_	
15-8	2418-2427	real-time	_	_	
15-9	2428-2436	analysis	_	_	
15-10	2437-2439	of	_	_	
15-11	2440-2443	the	_	_	
15-12	2444-2451	seizure	_	_	
15-13	2452-2460	activity	_	_	
15-14	2461-2466	still	_	_	
15-15	2467-2473	cannot	_	_	
15-16	2474-2476	be	_	_	
15-17	2477-2485	achieved	_	_	
15-18	2485-2486	.	_	_	

#Text=Another means for seizure foci localization is to drill holes into the cranium, and insert electrodes to record and analyze the electrical activity from the brain to determine the location of the foci.
16-1	2487-2494	Another	_	_	
16-2	2495-2500	means	_	_	
16-3	2501-2504	for	_	_	
16-4	2505-2512	seizure	_	_	
16-5	2513-2517	foci	_	_	
16-6	2518-2530	localization	_	_	
16-7	2531-2533	is	_	_	
16-8	2534-2536	to	_	_	
16-9	2537-2542	drill	_	_	
16-10	2543-2548	holes	_	_	
16-11	2549-2553	into	_	_	
16-12	2554-2557	the	_	_	
16-13	2558-2565	cranium	_	_	
16-14	2565-2566	,	_	_	
16-15	2567-2570	and	_	_	
16-16	2571-2577	insert	_	_	
16-17	2578-2588	electrodes	_	_	
16-18	2589-2591	to	_	_	
16-19	2592-2598	record	_	_	
16-20	2599-2602	and	_	_	
16-21	2603-2610	analyze	_	_	
16-22	2611-2614	the	_	_	
16-23	2615-2625	electrical	_	_	
16-24	2626-2634	activity	_	_	
16-25	2635-2639	from	_	_	
16-26	2640-2643	the	_	_	
16-27	2644-2649	brain	_	_	
16-28	2650-2652	to	_	_	
16-29	2653-2662	determine	_	_	
16-30	2663-2666	the	_	_	
16-31	2667-2675	location	_	_	
16-32	2676-2678	of	_	_	
16-33	2679-2682	the	_	_	
16-34	2683-2687	foci	_	_	
16-35	2687-2688	.	_	_	

#Text=The latter technique is extremely invasive, requires a neurosurgeon, and can lead to complications.
17-1	2689-2692	The	_	_	
17-2	2693-2699	latter	_	_	
17-3	2700-2709	technique	_	_	
17-4	2710-2712	is	_	_	
17-5	2713-2722	extremely	_	_	
17-6	2723-2731	invasive	_	_	
17-7	2731-2732	,	_	_	
17-8	2733-2741	requires	_	_	
17-9	2742-2743	a	_	_	
17-10	2744-2756	neurosurgeon	_	_	
17-11	2756-2757	,	_	_	
17-12	2758-2761	and	_	_	
17-13	2762-2765	can	_	_	
17-14	2766-2770	lead	_	_	
17-15	2771-2773	to	_	_	
17-16	2774-2787	complications	_	_	
17-17	2787-2788	.	_	_	

#Text=Similar techniques are applicable for the treatment of Parkinson's disease and other neurological disorders.
18-1	2789-2796	Similar	_	_	
18-2	2797-2807	techniques	_	_	
18-3	2808-2811	are	_	_	
18-4	2812-2822	applicable	_	_	
18-5	2823-2826	for	_	_	
18-6	2827-2830	the	_	_	
18-7	2831-2840	treatment	_	_	
18-8	2841-2843	of	_	_	
18-9	2844-2855	Parkinson's	_	_	
18-10	2856-2863	disease	_	_	
18-11	2864-2867	and	_	_	
18-12	2868-2873	other	_	_	
18-13	2874-2886	neurological	_	_	
18-14	2887-2896	disorders	_	_	
18-15	2896-2897	.	_	_	

#Text=Another problem that neither of these techniques can overcome is that the foci may move to various other locations.
19-1	2898-2905	Another	_	_	
19-2	2906-2913	problem	_	_	
19-3	2914-2918	that	_	_	
19-4	2919-2926	neither	_	_	
19-5	2927-2929	of	_	_	
19-6	2930-2935	these	_	_	
19-7	2936-2946	techniques	_	_	
19-8	2947-2950	can	_	_	
19-9	2951-2959	overcome	_	_	
19-10	2960-2962	is	_	_	
19-11	2963-2967	that	_	_	
19-12	2968-2971	the	_	_	
19-13	2972-2976	foci	_	_	
19-14	2977-2980	may	_	_	
19-15	2981-2985	move	_	_	
19-16	2986-2988	to	_	_	
19-17	2989-2996	various	_	_	
19-18	2997-3002	other	_	_	
19-19	3003-3012	locations	_	_	
19-20	3012-3013	.	_	_	

#Text=The fMRI and other similar imaging systems, such as positron emission tomography (PET), depend on blood flow changes, which can take many seconds to minutes to occur and thus unable to capture images of fast changing brain activity.
20-1	3014-3017	The	_	_	
20-2	3018-3022	fMRI	_	_	
20-3	3023-3026	and	_	_	
20-4	3027-3032	other	_	_	
20-5	3033-3040	similar	_	_	
20-6	3041-3048	imaging	_	_	
20-7	3049-3056	systems	_	_	
20-8	3056-3057	,	_	_	
20-9	3058-3062	such	_	_	
20-10	3063-3065	as	_	_	
20-11	3066-3074	positron	_	_	
20-12	3075-3083	emission	_	_	
20-13	3084-3094	tomography	_	_	
20-14	3095-3096	(	_	_	
20-15	3096-3099	PET	_	_	
20-16	3099-3100	)	_	_	
20-17	3100-3101	,	_	_	
20-18	3102-3108	depend	_	_	
20-19	3109-3111	on	_	_	
20-20	3112-3117	blood	_	_	
20-21	3118-3122	flow	_	_	
20-22	3123-3130	changes	_	_	
20-23	3130-3131	,	_	_	
20-24	3132-3137	which	_	_	
20-25	3138-3141	can	_	_	
20-26	3142-3146	take	_	_	
20-27	3147-3151	many	_	_	
20-28	3152-3159	seconds	_	_	
20-29	3160-3162	to	_	_	
20-30	3163-3170	minutes	_	_	
20-31	3171-3173	to	_	_	
20-32	3174-3179	occur	_	_	
20-33	3180-3183	and	_	_	
20-34	3184-3188	thus	_	_	
20-35	3189-3195	unable	_	_	
20-36	3196-3198	to	_	_	
20-37	3199-3206	capture	_	_	
20-38	3207-3213	images	_	_	
20-39	3214-3216	of	_	_	
20-40	3217-3221	fast	_	_	
20-41	3222-3230	changing	_	_	
20-42	3231-3236	brain	_	_	
20-43	3237-3245	activity	_	_	
20-44	3245-3246	.	_	_	

#Text=A moving seizure focus is at best difficult to map with electrodes inserted into the brain; it may take many electrodes and many holes in the cranium to track the moving foci.
#Text=[0015] The use of electroencephalogram (EEG) is another approach to epilepsy therapy.
21-1	3247-3248	A	_	_	
21-2	3249-3255	moving	_	_	
21-3	3256-3263	seizure	_	_	
21-4	3264-3269	focus	_	_	
21-5	3270-3272	is	_	_	
21-6	3273-3275	at	_	_	
21-7	3276-3280	best	_	_	
21-8	3281-3290	difficult	_	_	
21-9	3291-3293	to	_	_	
21-10	3294-3297	map	_	_	
21-11	3298-3302	with	_	_	
21-12	3303-3313	electrodes	_	_	
21-13	3314-3322	inserted	_	_	
21-14	3323-3327	into	_	_	
21-15	3328-3331	the	_	_	
21-16	3332-3337	brain	_	_	
21-17	3337-3338	;	_	_	
21-18	3339-3341	it	_	_	
21-19	3342-3345	may	_	_	
21-20	3346-3350	take	_	_	
21-21	3351-3355	many	_	_	
21-22	3356-3366	electrodes	_	_	
21-23	3367-3370	and	_	_	
21-24	3371-3375	many	_	_	
21-25	3376-3381	holes	_	_	
21-26	3382-3384	in	_	_	
21-27	3385-3388	the	_	_	
21-28	3389-3396	cranium	_	_	
21-29	3397-3399	to	_	_	
21-30	3400-3405	track	_	_	
21-31	3406-3409	the	_	_	
21-32	3410-3416	moving	_	_	
21-33	3417-3421	foci	_	_	
21-34	3421-3422	.	_	_	
21-35	3423-3424	[	_	_	
21-36	3424-3428	0015	_	_	
21-37	3428-3429	]	_	_	
21-38	3430-3433	The	_	_	
21-39	3434-3437	use	_	_	
21-40	3438-3440	of	_	_	
21-41	3441-3461	electroencephalogram	_	_	
21-42	3462-3463	(	_	_	
21-43	3463-3466	EEG	_	_	
21-44	3466-3467	)	_	_	
21-45	3468-3470	is	_	_	
21-46	3471-3478	another	_	_	
21-47	3479-3487	approach	_	_	
21-48	3488-3490	to	_	_	
21-49	3491-3499	epilepsy	_	_	
21-50	3500-3507	therapy	_	_	
21-51	3507-3508	.	_	_	

#Text=EEG is a method for recording brain electrical activity non-invasively from the scalp surface.
22-1	3509-3512	EEG	_	_	
22-2	3513-3515	is	_	_	
22-3	3516-3517	a	_	_	
22-4	3518-3524	method	_	_	
22-5	3525-3528	for	_	_	
22-6	3529-3538	recording	_	_	
22-7	3539-3544	brain	_	_	
22-8	3545-3555	electrical	_	_	
22-9	3556-3564	activity	_	_	
22-10	3565-3579	non-invasively	_	_	
22-11	3580-3584	from	_	_	
22-12	3585-3588	the	_	_	
22-13	3589-3594	scalp	_	_	
22-14	3595-3602	surface	_	_	
22-15	3602-3603	.	_	_	

#Text=It can have very good temporal resolution, less than 1.0 ms per sample.
23-1	3604-3606	It	_	_	
23-2	3607-3610	can	_	_	
23-3	3611-3615	have	_	_	
23-4	3616-3620	very	_	_	
23-5	3621-3625	good	_	_	
23-6	3626-3634	temporal	_	_	
23-7	3635-3645	resolution	_	_	
23-8	3645-3646	,	_	_	
23-9	3647-3651	less	_	_	
23-10	3652-3656	than	_	_	
23-11	3657-3660	1.0	_	_	
23-12	3661-3663	ms	_	_	
23-13	3664-3667	per	_	_	
23-14	3668-3674	sample	_	_	
23-15	3674-3675	.	_	_	

#Text=EEG can also be a portable system and without being exceedingly expensive.
24-1	3676-3679	EEG	_	_	
24-2	3680-3683	can	_	_	
24-3	3684-3688	also	_	_	
24-4	3689-3691	be	_	_	
24-5	3692-3693	a	_	_	
24-6	3694-3702	portable	_	_	
24-7	3703-3709	system	_	_	
24-8	3710-3713	and	_	_	
24-9	3714-3721	without	_	_	
24-10	3722-3727	being	_	_	
24-11	3728-3739	exceedingly	_	_	
24-12	3740-3749	expensive	_	_	
24-13	3749-3750	.	_	_	

#Text=However, EEG does have its limitations, such as the difficulty of localizing, with the type of electrodes used, the sources within the brain due to the smoothing affects of the skull and other body tissue.
25-1	3751-3758	However	_	_	
25-2	3758-3759	,	_	_	
25-3	3760-3763	EEG	_	_	
25-4	3764-3768	does	_	_	
25-5	3769-3773	have	_	_	
25-6	3774-3777	its	_	_	
25-7	3778-3789	limitations	_	_	
25-8	3789-3790	,	_	_	
25-9	3791-3795	such	_	_	
25-10	3796-3798	as	_	_	
25-11	3799-3802	the	_	_	
25-12	3803-3813	difficulty	_	_	
25-13	3814-3816	of	_	_	
25-14	3817-3827	localizing	_	_	
25-15	3827-3828	,	_	_	
25-16	3829-3833	with	_	_	
25-17	3834-3837	the	_	_	
25-18	3838-3842	type	_	_	
25-19	3843-3845	of	_	_	
25-20	3846-3856	electrodes	_	_	
25-21	3857-3861	used	_	_	
25-22	3861-3862	,	_	_	
25-23	3863-3866	the	_	_	
25-24	3867-3874	sources	_	_	
25-25	3875-3881	within	_	_	
25-26	3882-3885	the	_	_	
25-27	3886-3891	brain	_	_	
25-28	3892-3895	due	_	_	
25-29	3896-3898	to	_	_	
25-30	3899-3902	the	_	_	
25-31	3903-3912	smoothing	_	_	
25-32	3913-3920	affects	_	_	
25-33	3921-3923	of	_	_	
25-34	3924-3927	the	_	_	
25-35	3928-3933	skull	_	_	
25-36	3934-3937	and	_	_	
25-37	3938-3943	other	_	_	
25-38	3944-3948	body	_	_	
25-39	3949-3955	tissue	_	_	
25-40	3955-3956	.	_	_	
